Arbutus Biopharma Corporation (ABUS) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-11-16
6:12 pm
Sale
2026-09-3013GARBUTUS BIOPHARMA CORP
ABUS
Two Seas Capital LP8,143,994
4.100%
-10,413,549decrease
(-56.11%)
Filing
History
2026-11-16
4:20 pm
Sale
2026-09-3013GARBUTUS BIOPHARMA CORP
ABUS
Whitefort Capital Master Fund, LP2,451,033
1.600%
-13,343,228decrease
(-84.48%)
Filing
History
2026-11-16
3:27 pm
Purchase
2026-09-3013GARBUTUS BIOPHARMA CORP
ABUS
NOMURA HOLDINGS INC
NMR
14,512,000
7.300%
14,512,000increase
(New Position)
Filing
History
2026-10-27
5:25 pm
Purchase
2026-09-3013GARBUTUS BIOPHARMA CORP
ABUS
BlackRock Inc.
BLK
14,331,732
7.200%
3,941,432increase
(+37.93%)
Filing
History
2026-10-07
4:35 pm
Purchase
2026-09-3013GARBUTUS BIOPHARMA CORP
ABUS
MORGAN STANLEY
MS
18,682,708
12.200%
1,295,310increase
(+7.45%)
Filing
History
2026-10-05
9:02 pm
Sale
2026-10-0113DARBUTUS BIOPHARMA CORP
ABUS
Roivant Sciences Ltd.
ROIV
29,880,079
19.500%
-8,967,383decrease
(-23.08%)
Filing
History
2026-09-04
6:32 pm
Unchanged
2026-09-0413GARBUTUS BIOPHARMA CORP
ABUS
Whitefort Capital Master Fund, LP15,794,261
8.000%
0
(Unchanged)
Filing
History
2026-08-12
3:02 pm
Sale
2026-06-3013GARBUTUS BIOPHARMA CORP
ABUS
MORGAN STANLEY
MS
17,387,398
8.800%
-8,522,939decrease
(-32.89%)
Filing
History
2026-05-15
5:29 pm
Purchase
2026-03-3113GARBUTUS BIOPHARMA CORP
ABUS
Two Seas Capital LP18,557,543
9.400%
5,968,385increase
(+47.41%)
Filing
History
2026-04-28
5:54 pm
Unchanged
2026-04-2413DARBUTUS BIOPHARMA CORP
ABUS
Whitefort Capital Master Fund, LP15,794,261
8.000%
0
(Unchanged)
Filing
History
2026-04-13
7:56 pm
Purchase
2026-04-1013DARBUTUS BIOPHARMA CORP
ABUS
Whitefort Capital Master Fund, LP15,794,261
8.100%
2,486,294increase
(+18.68%)
Filing
History
2026-02-17
4:21 pm
Purchase
2025-12-3113GARBUTUS BIOPHARMA CORP
ABUS
Two Seas Capital LP12,589,158
6.500%
2,145,841increase
(+20.55%)
Filing
History
2026-02-11
1:45 pm
Purchase
2025-12-3113GARBUTUS BIOPHARMA CORP
ABUS
MORGAN STANLEY
MS
25,910,337
13.500%
4,385,676increase
(+20.38%)
Filing
History
2025-08-13
5:40 pm
Purchase
2025-06-3013GARBUTUS BIOPHARMA CORP
ABUS
Two Seas Capital LP10,443,317
5.400%
2,055,929increase
(+24.51%)
Filing
History
2025-02-25
07:19 am
Unchanged
2025-02-2113DARBUTUS BIOPHARMA CORP
ABUS
Roivant Sciences Ltd.
ROIV
38,847,462
20.500%
0
(Unchanged)
Filing
History
2025-02-21
09:00 am
Purchase
2025-02-2013DARBUTUS BIOPHARMA CORP
ABUS
Whitefort Capital Master Fund, LP13,307,967
7.000%
440,000increase
(+3.42%)
Filing
History
2025-02-18
5:21 pm
Unchanged
2025-02-1813DARBUTUS BIOPHARMA CORP
ABUS
Roivant Sciences Ltd.
ROIV
38,847,462
20.500%
0
(Unchanged)
Filing
History
2025-02-03
3:26 pm
Purchase
2024-12-3113GARBUTUS BIOPHARMA CORP
ABUS
MORGAN STANLEY
MS
21,524,661
11.400%
2,132,173increase
(+10.99%)
Filing
History
2024-11-14
08:41 am
Sale
2024-09-3013GARBUTUS BIOPHARMA CORP
ABUS
Two Seas Capital LP8,387,388
4.400%
-654,539decrease
(-7.24%)
Filing
History
2024-06-10
4:50 pm
Purchase
2024-05-3113GARBUTUS BIOPHARMA CORP
ABUS
MORGAN STANLEY
MS
19,392,488
10.300%
17,954,224increase
(+1248.33%)
Filing
History
Goto 0, 1, Next